Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo
Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo
The study shall prove whether 6 consecutive doses of Bifonazole spray show comparable
 efficacy to a Terbinafine solution applied once.
Inclusion Criteria:

 -  Male or female subjects aged between 18 and 70 years

 -  Positive clinical findings of athlete's foot, limited to interdigital spaces, with a
 total athlete's foot severity score (AFSS) of at least 5 and not exceeding 10 points
 for the signs and symptoms of athlete's foot, and no sign or symptom scoring 'severe'

 Exclusion Criteria:

 -  Clinical history suggestive of intolerance or allergies to one of the products or the
 ingredients of the products

 -  Plantar tinea pedis ("Mocassin-type")

 -  Onychomycosis of any toe

 -  Previous treatment with a systemic antifungal within 6 months prior to screening

 -  Previous treatment of feet with a topical antifungal within 4 weeks prior to screening

 -  Previous treatment with a topical antifungal applied to other areas of the body than
 feet within 2 weeks prior to screening

 -  Previous treatment of any topical medication applied to the feet within 2 weeks prior
 to screening